Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular CarcinomaT.S.K. Wan, Chun‐Ming Wong|Cellular and Molecular Gastroenterology and Hepatology|2025Cited by 2